Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Vertice Pharma

Vertice Pharma?uq=UG6efJS6
2015 FOUNDED
PRIVATE STATUS
Platform LATEST DEAL TYPE
1 FINANCING ROUNDS
1 INVESTMENTS
Description

Operator of a specialty branded and generic pharmaceuticals platform focused on improving patients' health. The company is engaged in acquiring specialty pharmaceuticals companies and products to create a durable specialty pharmaceutical platform of scale.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Holding Companies
Other Industries
Pharmaceuticals
Primary Office
  • 630 Central Avenue
  • New Providence, NJ 07974
  • United States

+1 (888) 000-0000

Vertice Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Vertice Pharma‘s full profile, request access.

Request full access to PitchBook

Vertice Pharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 22-Dec-2015 0000000000 Pharmaceuticals 000 00000000
To view this company’s complete investment and acquisition history, request access »

Vertice Pharma Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Vertice Pharma‘s full profile, request access.

Request full access to PitchBook

Vertice Pharma Executive Team (4)

Name Title Board
Seat
Contact
Info
Don DeGolyer Chief Executive Officer & Co-Founder
Ozgur Kilic Chief Financial Officer
Scott Meyers Chief Operating Officer

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »